[en] Phenylketonuria (PKU) is a metabolic genetic disease characterized by deficient phenylalanine hydroxylase (PAH) enzymatic activity. Brain hypomyelination has been reported in untreated patients, but its mechanism remains unclear. We therefore investigated the influence of phenylalanine (Phe), phenylpyruvate (PP), and phenylacetate (PA) on oligodendrocytes. We first showed in a mouse model of PKU that the number of oligodendrocytes is not different in corpus callosum sections from adult mutants or from control brains. Then, using enriched oligodendroglial cultures, we detected no cytotoxic effect of high concentrations of Phe, PP, or PA. Finally, we analyzed the impact of Phe, PP, and PA on the myelination process in myelinating cocultures using both an in vitro index of myelination, based on activation of the myelin basic protein (MBP) promoter, and the direct quantification of myelin sheaths by both optical measurement and a bioinformatics method. None of these parameters was affected by the increased levels of Phe or its derivatives. Taken together, our data demonstrate that high levels of Phe, such as in PKU, are unlikely to directly induce brain hypomyelination, suggesting involvement of alternative mechanisms in this myelination defect.
K Ahring A Belanger-Quintana K Dokoupil, et al. 2009 Dietary management practices in phenylketonuria across European centres Clin Nutr 28 3 231 236 10.1016/j.clnu.2009.03.004 1:CAS:528:DC%2BD1MXntVKgtL4%3D 19362397
G Barbin MS Aigrot P Charles, et al. 2004 Axonal cell-adhesion molecule L1 in CNS myelination Neuron Glia Biol 1 1 65 72 10.1017/S1740925X04000092 1:STN:280:DC%2BD1cvmsFCgsQ%3D%3D 18634607
N Baumann D Pham-Dinh 2001 Biology of oligodendrocyte and myelin in the mammalian central nervous system Physiol Rev 81 2 871 927 1:CAS:528: DC%2BD3MXislCrsbw%3D 11274346
J Bottenstein I Hayashi S Hutchings, et al. 1979 The growth of cells in serum-free hormone-supplemented media Methods Enzymol 58 94 109 10.1016/S0076-6879(79)58127-0 1:CAS:528:DyaE1MXkvVKrtbw%3D 423795
S Cabib T Pascucci R Ventura V Romano S Puglisi-Allegra 2003 The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria Behav Genet 33 3 301 310 10.1023/A:1023498508987 12837019 (Pubitemid 36638000)
P Charles MP Hernandez B Stankoff, et al. 2000 Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule Proc Natl Acad Sci U S A 97 13 7585 7590 10.1073/pnas.100076197 1:CAS:528:DC%2BD3cXksVKhsLc%3D 10840047 (Pubitemid 30431507)
C Demerens B Stankoff B Zalc C Lubetzki 1999 Eliprodil stimulates CNS myelination: new prospects for multiple sclerosis? Neurology 52 2 346 350 1:CAS:528:DyaK1MXht1yjtb0%3D 9932955
CA Dyer 2000 Comments on the neuropathology of phenylketonuria Eur J Pediatr 159 Suppl 2 S107 S108 10.1007/PL00014369 11043155
CA Dyer A Kendler T Philibotte P Gardiner J Cruz HL Levy 1996 Evidence for central nervous system glial cell plasticity in phenylketonuria J Neuropathol Exp Neurol 55 7 795 814 10.1097/00005072-199607000-00005 1:CAS:528:DyaK28XksFyru7w%3D 8965095
A Gow VL Friedrich Jr RA Lazzarini 1992 Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression J Cell Biol 119 3 605 616 10.1083/jcb.119.3.605 1:CAS:528:DyaK38Xmt1Omt78%3D 1383235
M Hoeksma DJ Reijngoud J Pruim HW de Valk AM Paans FJ van Spronsen 2009 Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis Mol Genet Metab 96 4 177 182 10.1016/j.ymgme.2008.12.019 1:CAS:528: DC%2BD1MXjt1agtbk%3D 19201235
F Horster MA Schwab SW Sauer, et al. 2006 Phenylalanine reduces synaptic density in mixed cortical cultures from mice Pediatr Res 59 4 Pt 1 544 548 10.1203/01.pdr.0000203091.45988.8d 16549526 (Pubitemid 43740053)
JV Hughes TC Johnson 1976 The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro J Neurochem 26 6 1105 1113 10.1111/j.1471-4159.1976.tb06993.x 1:CAS:528:DyaE28XlsFCmtr8%3D 932716
PR Huttenlocher 2000 The neuropathology of phenylketonuria: human and animal studies Eur J Pediatr 159 Suppl 2 S102 S106 10.1007/PL00014371 11043154
B Joseph CA Dyer 2003 Relationship between myelin production and dopamine synthesis in the PKU mouse brain J Neurochem 86 3 615 626 10.1046/j.1471-4159. 2003.01887.x 1:CAS:528:DC%2BD3sXlvF2ntbY%3D 12859675 (Pubitemid 36897442)
S Kaufman 1989 An evaluation of the possible neurotoxicity of metabolites of phenylalanine J Pediatr 114 5 895 900 10.1016/S0022-3476(89)80161-1 1:CAS:528:DyaL1MXktVGjtL0%3D 2654351 (Pubitemid 19122996)
R Matalon K Michals-Matalon G Bhatia, et al. 2007 Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine J Inherit Metab Dis 30 2 153 158 10.1007/s10545-007-0556-4 1:CAS:528:DC%2BD2sXjt1Wlsrs%3D 17334706 (Pubitemid 46487995)
KD McCarthy J de Vellis 1980 Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J Cell Biol 85 3 890 902 10.1083/jcb.85.3.890 1:CAS:528:DyaL3cXkvFaltL0%3D 6248568 (Pubitemid 10007455)
JD McDonald CK Charlton 1997 Characterization of mutations at the mouse phenylalanine hydroxylase locus Genomics 39 3 402 405 10.1006/geno.1996.4508 1:CAS:528:DyaK2sXht1ymu7s%3D 9119379 (Pubitemid 27078708)
RH Miller 2002 Regulation of oligodendrocyte development in the vertebrate CNS Prog Neurobiol 67 6 451 467 10.1016/S0301-0082(02)00058-8 1:CAS:528:DC%2BD38XnvVKjsr0%3D 12385864 (Pubitemid 35232446)
WM Pardridge 1998 Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids Neurochem Res 23 5 635 644 10.1023/A: 1022482604276 1:CAS:528:DyaK1cXisV2rsLs%3D 9566601 (Pubitemid 28173568)
T Pascucci R Ventura S Puglisi-Allegra S Cabib 2002 Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria NeuroReport 13 18 2561 2564 10.1097/00001756-200212200-00036 1:CAS:528:DC%2BD38Xpslartrs%3D 12499868 (Pubitemid 36143563)
AL Pey LR Desviat A Gamez M Ugarte B Perez 2003 Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH Hum Mutat 21 4 370 378 10.1002/humu.10198 1:CAS:528:DC%2BD3sXjtFKrtbg%3D 12655546 (Pubitemid 36389826)
JC Rocha F Martel 2009 Large neutral amino acids supplementation in phenylketonuric patients J Inherit Metab Dis 32 4 472 480 10.1007/s10545-009- 1132-x 1:CAS:528:DC%2BD1MXpslClt7o%3D 19437129
CN Sarkissian DM Boulais JD McDonald CR Scriver 2000 A heteroallelic mutant mouse model: a new orthologue for human hyperphenylalaninemia Mol Genet Metab 69 3 188 194 10.1006/mgme.2000.2974 1:CAS:528:DC%2BD3cXisVGisbc%3D 10767173 (Pubitemid 30241684)
CN Sarkissian CR Scriver OA Mamer 2000 Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization-gas chromatography/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia Anal Biochem 280 2 242 249 10.1006/abio.2000.4542 1:CAS:528:DC%2BD3cXivVWlsrc%3D 10790306 (Pubitemid 30308078)
S Schindeler S Ghosh-Jerath S Thompson, et al. 2007 The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study Mol Genet Metab 91 1 48 54 10.1016/j.ymgme.2007.02.002 1:CAS:528: DC%2BD2sXkt1ehurs%3D 17368065 (Pubitemid 46550929)
Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, (eds); Childs B, Kinzler KW, Vogelstein B (associated eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1667-1724
S Shefer GS Tint D Jean-Guillaume, et al. 2000 Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61 5 549 563 10.1002/1097- 4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0 1:CAS:528: DC%2BD3cXmsFGqur8%3D 10956425
CB Smith J Kang 2000 Cerebral protein synthesis in a genetic mouse model of phenylketonuria Proc Natl Acad Sci U S A 97 20 11014 11019 10.1073/pnas.97.20.11014 1:CAS:528:DC%2BD3cXnt1ahtr4%3D 11005872
I Sommer M Schachner 1981 Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system Dev Biol 83 2 311 327 10.1016/0012-1606(81)90477-2 1:STN:280: DyaL3M3htlWrtA%3D%3D 6786942
B Stankoff MS Aigrot F Noel A Wattilliaux B Zalc C Lubetzki 2002 Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules J Neurosci 22 21 9221 9227 1:CAS:528:DC%2BD3sXmsVenu7k%3D 12417647
R Surtees N Blau 2000 The neurochemistry of phenylketonuria Eur J Pediatr 159 Suppl 2 S109 S113 10.1007/PL00014370 1:CAS:528:DC%2BD3cXlvFOqt7o%3D 11043156
FJ van Spronsen M Hoeksma DJ Reijngoud 2009 Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32 1 46 51 10.1007/s10545-008-0946-2 19191004
RA Williams CD Mamotte JR Burnett 2008 Phenylketonuria: an inborn error of phenylalanine metabolism Clin Biochem Rev 29 1 31 41 18566668
Wu C, Schulte J, Sepp KJ, Littleton JT, Hong P (Submitted) Robust Neurite Detection and Automatic Morphological Analysis of Optical Microscopy Neuron Cell Culture Images in High-Content Screening. Neuroinformatics
T Yamamura JT Konola H Wekerle MB Lees 1991 Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants J Neurochem 57 5 1671 1680 10.1111/j.1471-4159.1991.tb06367.x 1:CAS:528:DyaK38XkvVSl 1717653
L Zagreda J Goodman DP Druin D McDonald A Diamond 1999 Cognitive deficits in a genetic mouse model of the most common biochemical cause of human mental retardation J Neurosci 19 14 6175 6182 1:CAS:528:DyaK1MXksVyku7o%3D 10407053